UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048522
Receipt number R000055262
Scientific Title The effects of low protein Genmai in CKD patients-Study on Kidney-gut axis-
Date of disclosure of the study information 2022/08/15
Last modified on 2022/07/30 06:04:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of low protein Genmai in CKD patients

Acronym

Low protein Genmai study

Scientific Title

The effects of low protein Genmai in CKD patients-Study on Kidney-gut axis-

Scientific Title:Acronym

Kidney-gut axis study

Region

Japan


Condition

Condition

Chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the change in clinical parameters by the low-protein brown rice

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

subjective findings, QOL
renal function
urinalysis
stool examination

Key secondary outcomes

Cytokine levels
uremic toxin levels
gut microbiota population
electrolytes
defecation comdition


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

low protein brown rice

Interventions/Control_2

usual low protein diret

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) CKD patient at stage 3 over
2) never experienced diet therapy
3) have given us an infoemed consent

Key exclusion criteria

1) cannot be got a sufficient materials
2) cannot understand the significance of diet therapy
3) have an inflammatory bowel disease

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shu
Middle name
Last name Wakino

Organization

Tokushima University Graduate School

Division name

Department of Nephrology

Zip code

770-8503

Address

3-18-15, Kuramoto, Tokushima

TEL

088-633-7183

Email

shuwakino@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Shu
Middle name
Last name Wakino

Organization

Tokushima University Graduate School

Division name

Department of Nephrology

Zip code

770-8503

Address

3-18-15, Kuramoto, Tokushima

TEL

088-633-7183

Homepage URL


Email

shuwakino@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

Cabinet Office

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Medical Rice Association

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Tokushima University Hospital

Address

2-50-1, Kuramoto, Tokushima

Tel

088-633-9294

Email

awachiken@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学病院(徳島県)


Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 07 Month 14 Day

Date of IRB


Anticipated trial start date

2022 Year 08 Month 15 Day

Last follow-up date

2024 Year 08 Month 14 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 30 Day

Last modified on

2022 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055262